These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25142226)

  • 1. Notable epigenetic role of hyperhomocysteinemia in atherogenesis.
    Zhou S; Zhang Z; Xu G
    Lipids Health Dis; 2014 Aug; 13():134. PubMed ID: 25142226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and atherosclerosis.
    Turunen MP; Aavik E; Ylä-Herttuala S
    Biochim Biophys Acta; 2009 Sep; 1790(9):886-91. PubMed ID: 19233248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No Effect of Diet-Induced Mild Hyperhomocysteinemia on Vascular Methylating Capacity, Atherosclerosis Progression, and Specific Histone Methylation.
    Whalen CA; Mattie FJ; Florindo C; van Zelst B; Huang NK; Tavares de Almeida I; Heil SG; Neuberger T; Ross AC; Castro R
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32717800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats.
    Jiang Y; Sun T; Xiong J; Cao J; Li G; Wang S
    Acta Biochim Biophys Sin (Shanghai); 2007 Sep; 39(9):657-67. PubMed ID: 17805460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.
    Naushad SM; Reddy CA; Kumaraswami K; Divyya S; Kotamraju S; Gottumukkala SR; Digumarti RR; Kutala VK
    Cell Biochem Biophys; 2014 Mar; 68(2):397-406. PubMed ID: 23934182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia.
    Perła-Kaján J; Jakubowski H
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in hyperhomocysteinemic states. A special focus on uremia.
    Ingrosso D; Perna AF
    Biochim Biophys Acta; 2009 Sep; 1790(9):892-9. PubMed ID: 19245874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction.
    Ciaccio M; Bellia C
    Curr Clin Pharmacol; 2010 Feb; 5(1):30-6. PubMed ID: 20236081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of homocysteine metabolism and associated disorders.
    Brustolin S; Giugliani R; Félix TM
    Braz J Med Biol Res; 2010 Jan; 43(1):1-7. PubMed ID: 19967264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia: an additional cardiovascular risk factor.
    Fanapour PC; Yug B; Kochar MS
    WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview.
    Castro R; Rivera I; Blom HJ; Jakobs C; Tavares de Almeida I
    J Inherit Metab Dis; 2006 Feb; 29(1):3-20. PubMed ID: 16601863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies.
    Sharma P; Senthilkumar RD; Brahmachari V; Sundaramoorthy E; Mahajan A; Sharma A; Sengupta S
    Lipids Health Dis; 2006 Jan; 5():1. PubMed ID: 16430779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis.
    Griñán R; Escolà-Gil JC; Julve J; Benítez S; Rotllan N
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism.
    Xiao Y; Su X; Huang W; Zhang J; Peng C; Huang H; Wu X; Huang H; Xia M; Ling W
    Int J Biochem Cell Biol; 2015 Oct; 67():158-66. PubMed ID: 26117455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of methylation in atherosclerosis accelerated by hyperhomocysteinemia].
    Wang N; Feng J; Wang X
    Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):267-71. PubMed ID: 23189620
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk factors for cardiovascular diseases: what is the role for homocysteine?].
    Bendini MG; Lanza GA; Mazza A; Giordano A; Leggio M; Menichini G; De Cristofaro R; Moriconi E; Cozzari L; Farina SM; Giordano G
    G Ital Cardiol (Rome); 2007 Mar; 8(3):148-60. PubMed ID: 17461357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues.
    Iacobazzi V; Infantino V; Castegna A; Andria G
    Mol Genet Metab; 2014; 113(1-2):27-33. PubMed ID: 25087163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired homocysteine metabolism and atherothrombotic disease.
    Durand P; Prost M; Loreau N; Lussier-Cacan S; Blache D
    Lab Invest; 2001 May; 81(5):645-72. PubMed ID: 11351038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.